BCRX
BioCryst Pharmaceuticals Inc
Price:  
7.53 
USD
Volume:  
1,597,198.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BCRX EV/EBITDA

-193.7%
Upside

As of 2024-12-14, the EV/EBITDA ratio of BioCryst Pharmaceuticals Inc (BCRX) is -58.36. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BCRX's latest enterprise value is 2,295.87 mil USD. BCRX's TTM EBITDA according to its financial statements is -39.34 mil USD. Dividing these 2 quantities gives us the above BCRX EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 15.1x - 18.6x 16.6x
Forward P/E multiples 15.3x - 26.1x 20.2x
Fair Price (6.46) - (7.08) (7.05)
Upside -185.8% - -194.0% -193.7%
7.53 USD
Stock Price
(7.05) USD
Fair Price

BCRX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-12-06 -58.78
2024-12-05 -59.99
2024-12-04 -57.30
2024-12-03 -56.57
2024-12-02 -57.57
2024-11-29 -58.20
2024-11-27 -58.20
2024-11-26 -58.14
2024-11-25 -56.99
2024-11-22 -58.72
2024-11-21 -58.14
2024-11-20 -57.14
2024-11-19 -56.67
2024-11-18 -55.88
2024-11-15 -55.72
2024-11-14 -57.93
2024-11-13 -58.93
2024-11-12 -59.88
2024-11-11 -61.83
2024-11-08 -59.67
2024-11-07 -59.09
2024-11-06 -59.41
2024-11-05 -55.85
2024-11-04 -57.41
2024-11-01 -63.09
2024-10-31 -60.88
2024-10-30 -62.78
2024-10-29 -61.46
2024-10-28 -61.62
2024-10-25 -60.57
2024-10-24 -61.78
2024-10-23 -61.15
2024-10-22 -60.57
2024-10-21 -58.30
2024-10-18 -58.83
2024-10-17 -58.14
2024-10-16 -58.57
2024-10-15 -58.09
2024-10-14 -57.99
2024-10-11 -57.83
2024-10-10 -56.20
2024-10-09 -56.88
2024-10-08 -56.62
2024-10-07 -57.88
2024-10-04 -58.62
2024-10-03 -57.78
2024-10-02 -57.57
2024-10-01 -57.57
2024-09-30 -58.72
2024-09-27 -58.83